INTERCALATION WITH DNA IS A PREREQUISITE FOR DAUNOMYCIN, ADRIAMYCIN AND ITS CONGENERS IN INHIBITING DNAASE I.FACCHINETTI T; MANTOVANI A; CANTONI L et al.1978; CHEMICO-BIOL. INTERACTIONS; NETHERL.; DA. 1978; VOL. 20; NO 1; PP. 97-102; BIBL. 10 REF.Article

INTERACTION OF ADRIAMYCIN IN VITRO WITH CARDIAC MYOFIBRILLAR PROTEINSLEWIS W; KLEINERMAN J; PUSZKIN S et al.1982; CIRC. RES.; ISSN 0009-7330; USA; DA. 1982; VOL. 50; NO 4; PP. 547-553; BIBL. 23 REF.Article

ADRIAMYCIN INDUCED IMMUNOMODULATION: DEPENDENCE UPON TIME OF ADMINISTRATIONEHRKE MJ; TOMAZIC V; RYOYAMA K et al.1983; INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY; ISSN 0192-0561; USA; DA. 1983; VOL. 5; NO 1; PP. 43-48; BIBL. 23 REF.Article

N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE, AN ANALOG WITH GREATER EXPERIMENTAL ANTITUMOR ACTIVITY AND LESS TOXICITY THAN ADRIAMYCIN = LE VALERATE-14 DE N-TRIFLUOROACETYLADRIAMYCINE, UN ANALOGUE AVEC UNE PLUS GRANDE ACTIVITE ANTITUMORALE EXPERIMENTALE ET UNE TOXICITE MOINDRE QUE L'ADRIAMYCINEISRAEL M; MODEST EJ; FREI E III et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 5; PP. 1365-1368; BIBL. 25REF.Article

INHIBITION OF DRUG OXIDATION AND STIMULATION OF NADPH OXIDASE IN VITRO BY DOXORUBICIN AND TRIFERRIC-DOXORUBICINVAN BOXTEL CJ; CHRASTIL J; WILSON JT et al.1979; PHARMACOLOGY; CHE; DA. 1979; VOL. 19; NO 1; PP. 5-11; BIBL. 14 REF.Article

A "HEXOKINASE EFFECT" IN THE INHIBITION OF OXIDATIVE PHOSPHORYLATION IN HEART MUSCLE MITOCHONDRIA BY ADRIAMYCINMUHAMMED H; RAMASARMA T; RAMAKRISHNA KURUP CK et al.1982; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1982; VOL. 105; NO 4; PP. 1440-1445; BIBL. 15 REF.Article

DEOXYRIBOSE BREACKDOWN BY THE ADRIAMYCIN SEMIQUINONE AND H₂O₂: EVIDENCE FOR HYDROXYL RADICAL PARTICIPATIONBATES DA; WINTERBOURN CC.1982; FEBS LETTERS; ISSN 0014-5793; NLD; DA. 1982; VOL. 145; NO 1; PP. 137-142; BIBL. 20 REF.Article

ETUDE ULTRASTRUCTURALE DE LA CARDIOTOXICITE ET DES ALTERATIONS DE LA PEAU CHEZ LE HAMSTER DORE APRES TRAITEMENT AVEC HUIT DIFFERENTES ANTHRACYCLINESDANTCHEV D; SLIOUSSARTCHOUK V; PAINTRAND M et al.1979; C.R. SOC. BIOL.; FRA; DA. 1979; VOL. 173; NO 2; PP. 394-413; BIBL. 12 REF.Article

CHEMOTHERAPEUTIC STUDY ON YOSHIDA SARCOMA ASCITES CELLS IMPLANTED INTO THE GLANDULAR STOMACH OF RATS: MONOTHERAPY WITH 5-FLUOROURACIL, METHYL-CCNU, MITOMYCIN C, ADRIAMYCIN, AND CYTOSINE ARABINOSIDE, AND COMBINATION THERAPY WITH RESPECTIVE TWO-DRUG COMBINATIONSEICHLER G; HABS M; SCHMAEHL D et al.1983; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1983; VOL. 105; NO 3; PP. 250-257; BIBL. 21 REF.Article

HYPERTHERMIC POTENTIATION OF DOXORUBICIN AND 4'-EPIDOXORUBICIN IN A TRANSPLANTABLE NEUROGENIC RAT TUMOR (BT₄A) IN BD IX RATS = POTENTIALISATION PAR HYPERTHERMIE DE LA DOXORUBICINE ET DE LA 4'-EPI-DOXORUBICINE DANS UNE TUMEUR NEUROGENE TRANSPLANTABLE DU RAT (BT₄A) CHEZ DES RATS BD IXDAHL O.1983; INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS; ISSN 0360-3016; USA; DA. 1983; VOL. 9; NO 2; PP. 203-207; ABS. ENG; BIBL. 30 REF.; GRAPHArticle

CHEMOTHERAPY OF HUMAN COLORECTAL TUMOR XENOGRAFTS IN ATHYMIC MICE WITH CLINICALLY ACTIVE DRUGS: 5-FLUOROURACILE AND 1-3 BIS-(-2CHLOROETHYL 1)-1-NITROSOUREA (BCNU). COMPARISON WITH DOXORUBICIN DERIVATIVE: 4' DEOXYDOXORUBICIN AND 4'-O-METHYLDOXORUBICINGIULIANI FC; ZIRVI KA; KAPLAN NO et al.1981; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1981; VOL. 27; NO 1; PP. 5-13; BIBL. 49 REF.Article

ULTRASTRUCTURAL STUDY OF THE CARDIOTOXICITY AND LIGHT-MICROSCOPIC FINDINGS OF THE SKIN AFTER TREATMENT OF GOLDEN HAMSTERS WITH SEVEN DIFFERENT ANTHRACYCLINESDANTCHEV D; SLIOUSSARTCHOUK V; PAINTRAND M et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 74; PP. 223-249; BIBL. 12 REF.Article

SYNTHESIS OF ADRIAMYCIN - COUPLED POLYGLUTARALDEHYDE MICROSPHERES AND EVALUATION OF THEIR CYTOSTATIC ACTIVITYTOKES ZA; ROGERS KE; REMBAUM A et al.1982; PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. BIOLOGICAL SCIENCES; ISSN 0273-1134; USA; DA. 1982; VOL. 79; NO 6; PP. 2026-2030; BIBL. 16 REF.Article

ADRIAMYCIN-ACTIVATED MACROPHAGES AS TUMOR GROWTH INHIBITORSHASKILL JS.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 10; PP. 3852-3856; BIBL. 16 REF.Article

DNA COMPLEXES OF DAUNORUBICIN (NSC-82151) AND ADRIAMYCINTROUET A; DE DUVE C.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 260; BIBL. 2REF.Article

POSSIBLE RELEVANCE OF N-TRIFLUOROACETYLADRIAMYCIN (AD 41) IN THE ANTITUMORAL ACTIVITY OF N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE (AD 32) IN TUMOR-BEARING MICE. I: PHARMACOKINETIC EVIDENCEABBRUZZI R; RIZZARDINI M; BENIGNI A et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 8-9; PP. 873-878; BIBL. 16 REF.Article

ELECTRON MICROSCOPIC STUDIES OF THE HEART AND LIGHT MICROSCOPIC STUDIES OF THE SKIN AFTER TREATMENT OF GOLDEN HAMSTERS WITH ADRIAMYCIN, DETORUBICIN, AD-32 AND ACLACINOMYCINDANTCHEV D; SILIOUSSARTCHOUK V; PAINTRAND M et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 875-888; BIBL. 8 REF.Article

COMPARATIVE ANTINEOPLASTIC ACTIVITY OF ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE.VECCHI A; CAIRO M; MANTOVANI A et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 1; PP. 111-117; BIBL. 22 REF.Article

HEPATOBILIARY METABOLISM AND EXCRETION OF ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE IN THE RAT.ISRAEL M; WILKINSON PM; PEGG WJ et al.1978; CANCER RES.; U.S.A.; DA. 1978; VOL. 38; NO 2; PP. 365-370; BIBL. 24 REF.Article

URINARY ANTHRACYCLINE METABOLITES FROM MICE TREATED WITH ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE.ISRAEEL M; PEGG WJ; WILKINSON PM et al.1978; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1978; VOL. 204; NO 3; PP. 696-701; BIBL. 18 REF.Article

ANTITUMOR ACTIVITY IN MICE OF 4'-DEOXYDOXORUBICIN IN COMPARISON WITH DOXORUBICIN = ACTIVITE ANTITUMORALE CHEZ LA SOURIS DE LA 4'-DESOXYDOXORUBICINE COMPAREE A CELLE DE LA DOXORUBICINECASAZZA AM; SAVI G; PRATESI G et al.1983; EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY; ISSN 0277-5379; GBR; DA. 1983; VOL. 19; NO 3; PP. 411-418; ABS. ENG; BIBL. 17 REF.; GRAPHArticle

IN VITRO RESPONSES OF NUDE MOUSE-XENOGRAFTED HUMAN COLON CARCINOMAS EXPOSED TO DOXORUBICIN DERIVATIVES IN TISSUE CULTURE AND IN THE MOUSEZIRVI KA; VAN DER BOSCH J; KAPLAN NO et al.1982; CANCER RES.; USA; DA. 1982; VOL. 42; NO 9; PP. 3793-3797; BIBL. 12 REF.Article

FLUORESCENCE ASSAYS AND PHARMACOKINETIC STUDIES OF 4'-DEOXYDOXORUBICIN AND DOXORUBICIN IN ORGANS OF MICE BEARING SOLID TUMORSFORMELLI F; POLLINI C; CASAZZA AM et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 5; NO 3; PP. 139-144; BIBL. 11 REF.Article

INHIBITION OF CARDIAC GUANYLATE CYCLASE BY DOXORUBICIN AND SOME OF ITS ANALOGS: POSSIBLE RELATIONSHIP TO CARDIOTOXICITYLEHOTAY DC; LEVEY BA; ROGERSON BJ et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 2; PP. 311-316; BIBL. 43 REF.Article

INHIBITION OF CHICKEN MYELOBLASTOSIS RNA POLYMERASE II ACTIVITY IN VITRO BY N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATECHUANG LF; KAWAHATA RT; CHUANG RY et al.1980; F.E.B.S. LETTERS; NLD; DA. 1980; VOL. 117; NO 1; PP. 247-251; BIBL. 16 REF.Article